Copyright
©The Author(s) 2024.
World J Clin Cases. Aug 6, 2024; 12(22): 4992-4998
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4992
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4992
Table 3 Comparative analysis of safety, n (%)
| Adverse reactions | Control group (n = 59) | Observation group (n = 60) | χ2 | P value |
| Dizziness and headache | 2 (3.39) | 0 (0.00) | ||
| Nausea and vomiting | 3 (5.08) | 0 (0.00) | ||
| Breast tenderness | 4 (6.78) | 2 (3.33) | ||
| Total | 9 (15.25) | 2 (3.33) | 5.039 | 0.025 |
- Citation: Kuang YY, Xiong MQ, Cai JX. Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome. World J Clin Cases 2024; 12(22): 4992-4998
- URL: https://www.wjgnet.com/2307-8960/full/v12/i22/4992.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.4992